Hippo kinases LATS1/2 control human breast cell fate via crosstalk with ERα

Autor: Christina Scheel, Zsuzsanna Varga, Michael B. Stadler, Mohamed Bentires-Alj, Sungeun Kim, Daniela Kaup, Kirsten D. Mertz, Adrian Britschgi, Shany Koren, Heike Brinkhaus, Alexandra Vissieres, Ghislain M. C. Bonamy, Joana Pinto Couto, Hans Voshol, Tim Roloff, Stephan Duss, Loren Miraglia, Duvini De Silva, Cédric Leroy, Venkateshwar A. Reddy, Anthony P. Orth
Přispěvatelé: University of Zurich, Bentires-Alj, Mohamed
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
Proteasome Endopeptidase Complex
medicine.medical_specialty
Ubiquitin-Protein Ligases
Cellular differentiation
610 Medicine & health
Cell fate determination
Biology
Protein Serine-Threonine Kinases
Article
03 medical and health sciences
Breast cancer
10049 Institute of Pathology and Molecular Pathology
Internal medicine
medicine
Humans
Cell Lineage
Genes
Tumor Suppressor

Hippo Signaling Pathway
Breast
Progenitor cell
skin and connective tissue diseases
Transcription factor
Cells
Cultured

Adaptor Proteins
Signal Transducing

1000 Multidisciplinary
Hippo signaling pathway
Multidisciplinary
Ubiquitin
Tumor Suppressor Proteins
Myoepithelial cell
Estrogen Receptor alpha
YAP-Signaling Proteins
Cell Differentiation
Phosphoproteins
medicine.disease
Research Highlight
3. Good health
Cell biology
030104 developmental biology
Endocrinology
Proteolysis
Female
Stem cell
Carrier Proteins
Transcription Factors
Signal Transduction
Zdroj: Nature
Nature 541, 541-545 (2017)
Popis: Cell fate perturbations underlie many human diseases, including breast cancer(1,2). Unfortunately, the mechanisms by which breast cell fate are regulated are largely unknown. The mammary gland epithelium consists of differentiated luminal epithelial and basal myoepithelial cells, as well as undifferentiated stem cells and more restricted progenitors(3,4). Breast cancer originates from this epithelium, but the molecular mechanisms that underlie breast epithelial hierarchy remain ill-defined. Here, we use a high-content confocal image-based short hairpin RNA screen to identify tumour suppressors that regulate breast cell fate in primary human breast epithelial cells. We show that ablation of the large tumour suppressor kinases (LATS) 1 and 2 (refs 5, 6), which are part of the Hippo pathway, promotes the luminal phenotype and increases the number of bipotent and luminal progenitors, the proposed cells-of-origin of most human breast cancers. Mechanistically, we have identified a direct interaction between Hippo and oestrogen receptor-alpha (ER alpha) signalling. In the presence of LATS, ERa was targeted for ubiquitination and Ddb1-cullin4-associated-factor 1 (DCAF1)-dependent proteasomal degradation. Absence of LATS stabilized ERa and the Hippo effectors YAP and TAZ (hereafter YAP/TAZ), which together control breast cell fate through intrinsic and paracrine mechanisms. Our findings reveal a non-canonical (that is, YAP/TAZ-independent) effect of LATS in the regulation of human breast cell fate.
Databáze: OpenAIRE